AR and posterior cortical atrophy: Our current study has shown that miR-99b-5p potentially serves as a therapeutic molecule to simultaneously inhibit AR and AR-V7 in the PCa, evident from the significant reduction of AR in all cell lines and AR-V7 in 22Rv1 treated with miR-99b-5p or miR-99b-5p/Enz (Figure 4).